Back to search
FDAFDA · Food and drugs·Recall number D-0518-2017

Triamcinolone 40 mg/mL 2 mL Single-Dose Vial for Injection, Preservative Free, Rx only, Compounded by Isomeric Pharmacy Solutions, Salt Lake City, UT 84109, NDC 70285-1920-1

Published March 22, 2017 · Recall initiated: March 8, 2017

Summary

FDA records drug Class II recall D-0518-2017, published March 22, 2017 and initiated March 8, 2017. Recalling firm: Isomeric Pharmacy Solution, LLC; Status: Terminated; Reported quantity: 6,999 single-use vials; Lot: Lot #08016; Exp. 03/14/17 Lot #08018; Exp. 03/15/17 Lot #08023; Exp. 03/22/17 Lot #08026; Exp. 03/19/17 Lot #08033; Exp. 03/28/17 Lot #09004; Exp. 04/03/17 Lot #11014; Exp. 06/10/17 Lot #11031; Exp. 06/20/17. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Isomeric Pharmacy Solution, LLC
Distributor
Nationwide
Lot
Lot #08016; Exp. 03/14/17 Lot #08018; Exp. 03/15/17 Lot #08023; Exp. 03/22/17 Lot #08026; Exp. 03/19/17 Lot #08033; Exp. 03/28/17 Lot #09004; Exp. 04/03/17 Lot #11014; Exp. 06/10/17 Lot #11031; Exp. 06/20/17
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Triamcinolone 40 mg/mL 2 mL Single-Dose Vial for Injection, Preservative Free, Rx only, Compounded by Isomeric Pharmacy Solutions, Salt Lake City, UT 84109, NDC 70285-1920-1 recalled?

Yes. FDA published recall D-0518-2017 on March 22, 2017. Reported hazard: CGMP Deviations

What should I do if I have this product?

Voluntary: Firm initiated · Letter